Sure there could be and the company explains who t
Post# of 72446
(Total Views: 217)
Posted On: 11/20/2017 4:56:51 PM
Sure there could be and the company explains who they could be in the 10-K. The company forecasts using $15.9M of Aspire between June 2017 and June 2018. That's 22M shares for the fiscal year at $0.70/share.
That's an average of ~90K shares per trading day. Now they've typically come in under estimates so lets cut the company provided estimate in half and call it ~45K shares per trading on average. Now, there's no guarentee that they are selling. They have not filed 5% ownership yet though so they have sold at least ~75% of what we have sold them up until now.
So yes, per company guidance, I would not be surprised to see a 40K sale from Aspire on a given day where they find a buyer.
Hopefully good results and a partnership changes this in the short term.
Go IPIX!
That's an average of ~90K shares per trading day. Now they've typically come in under estimates so lets cut the company provided estimate in half and call it ~45K shares per trading on average. Now, there's no guarentee that they are selling. They have not filed 5% ownership yet though so they have sold at least ~75% of what we have sold them up until now.
So yes, per company guidance, I would not be surprised to see a 40K sale from Aspire on a given day where they find a buyer.
Hopefully good results and a partnership changes this in the short term.
Go IPIX!
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.